PROVECTUS BIOPHARMACEUTICALS, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-06-30 was $583.43K.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-03-31 was $491.50K.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-09-30 was $972.60K, a 176.91% increase year-over-year.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-06-30 was $783.30K, a 45.00% increase year-over-year.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $945.46K, a 30.56% decline from fiscal 2022.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $1.36M, a 61.55% decline from fiscal 2021.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $3.54M.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2013 was -$29.06K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-06-30 | $583.43K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $491.50K 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $972.60K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $783.30K 10-Q · filed 2024-11-12 | |
| 2024-03-31 | $648.16K 10-Q · filed 2024-11-12 | |
| 2023-12-31 | $945.46K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $351.23K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $540.22K 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $54.01K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $1.36M 10-K · filed 2024-03-28 | |
| 2021-12-31 | $3.54M 10-K · filed 2023-03-30 | |
| 2021-06-30 | $3.54M 10-Q · filed 2022-11-09 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$29.06K 10-K · filed 2014-03-13 |
| 2010-12-31 | $0.00 10-Q · filed 2012-05-09 | |
| 2007-12-31 | $367.50K 10-Q · filed 2014-08-07 | |
| 2006-12-31 | $1.58M 10-Q · filed 2014-08-07 | |
| 2005-12-31 | $3.05M 10-Q · filed 2014-08-07 |